Age of the company
8 yearsCapital in CHF
100'000Active brands
3Reports for BioSwiss Pharmaceutical SA
Credit rating information
Evaluation of credit rating with traffic light as risk indicator and other helpful data about the company. Find out moreEconomic information
Comprehensive information about the economic situation of a company. Find out morePayment collection information
Overview of current and past debt enforcement proceedings. Find out moreCompany dossier as PDF
Contact information, changes in the company, turnover and employee figures, management, ownership, shareholding structure and other company data. Retrieve company dossierAbout BioSwiss Pharmaceutical SA
- BioSwiss Pharmaceutical SA in Genève is a Company limited by shares (AG) from the sector «Trading in consumer goods». BioSwiss Pharmaceutical SA is active.
- BioSwiss Pharmaceutical SA was founded on 30.09.2015.
- All past changes can be viewed and saved as a PDF under the section «Notifications». The last change in the commercial register was made on 23.02.2018.
- In the commercial register the company BioSwiss Pharmaceutical SA is registered under the UID CHE-188.326.257.
- View all information about the 3 trademarks registered by the company BioSwiss Pharmaceutical SA.
- Companies with an identical address: "Dypro" Dynamic Instruction Programs AG, ABCYB Sàrl, Acenium SA.
Commercial register information
Entry in the commercial register
30.09.2015
Legal form
Company limited by shares (AG)
Legal headquarters of the company
Genève
Commercial Registry Office
GE
Commercial register number
CH-660.5.964.015-3
UID/VAT
CHE-188.326.257
Sector
Trading in consumer goods
Purpose (Original language) Customise the company purpose with just a few clicks.
Intermédiation commerciale, trading, mise en relation, conseil en montage financier et en stratégie d'entreprise, investissement, ainsi que distribution de produits pharmaceutiques (cf. statuts pour but complet).
Other company names
Es sind keine früheren oder übersetzten Firmannamen vorhanden.
Would you like to update the company name? Click here.Ownership structure
Holdings
Trademarks
| Trademark | Registration date | Status | Number |
|---|---|---|---|
|
15.08.2016 | active | 54859/2016 |
| GSB Alliances | 11.08.2016 | active | 54854/2016 |
Newest SOGC notifications: BioSwiss Pharmaceutical SA
The latest updates from the Swiss Official Gazette of Commerce (SOGC) are available in the original language of the source commercial register office only. View all notifications
Publication number: 4075649, Commercial Registry Office Geneva, (660)
BioSwiss Pharmaceutical SA, à Genève, CHE-188.326.257 (FOSC du 05.10.2015, p. 0/2407731). Conversion des 100'000 actions de CHF 1, jusqu'ici au porteur, en actions nominatives, liées selon statuts.
Capital-actions:
CHF 100'000, entièrement libéré, divisé en 100'000 actions de CHF 1, nominatives, liées selon statuts.
Communication aux actionnaires:
lettre recommandée. Nouveaux statuts du 16.02.2018. Boccard Christian et Righetti Roberto ne sont plus administrateurs et leurs pouvoirs sont radiés.
Administration:
Serodino Christophe, d'Onsernone, à Thônex, administrateur unique avec signature individuelle.
Publication number: 2407731, Commercial Registry Office Geneva, (660)
BioSwiss Pharmaceutical SA, à Genève, rue Adrien-Lachenal 20, 1207 Genève, CHE-188.326.257. Nouvelle société anonyme. Statuts du 23.09.2015.
But:
intermédiation commerciale, trading, mise en relation, conseil en montage financier et en stratégie d'entreprise, investissement, ainsi que distribution de produits pharmaceutiques (cf. statuts pour but complet).
Capital-actions:
CHF 100'000, entièrement libéré, divisé en 100'000 actions de CHF 1, au porteur.
Organe de publication:
Feuille Officielle Suisse du Commerce.
Communication aux actionnaires:
Feuille Officielle Suisse du Commerce ou lettre recommandée s'ils sont tous connus.
Administration:
Boccard Christian, de France, à Gaillard, F, président, et Righetti Roberto, de Nendaz, à Plan-les-Ouates, tous deux avec signature individuelle. Selon déclaration du 23.09.2015, il est renoncé à un contrôle restreint.